|
BIVIGAM (immune globulin intravenous (human) 10% liquid) is indicated for the treatment of primary humoral immunodeficiency, including but not limited to the humoral immune defect in common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome and severe combined immunodeficiencies. The product has a median half-life of 30 days, contains no sucrose/glucose/maltose, is stabilized with glycine, has trace amounts of IgA, contains a latex-free stopper, features tamper-evident seals and can be stored for up to 24 months (until expiration date on vial packaging) at 2 degrees to 8 degrees Centigrade.
For more information about Bivigam, go to biosupply.fffenterprises.com
• Adynovate (Baxalta)
ADYNOVATE is a factor VIII antihemophilic factor (Recombinant), PEGylated. Indicated in adolescent and adult patients (12 years and older) with hemophilia A for: 1) on-demand treatment and control of bleeding episodes; and 2) routine prophylaxis to reduce the frequency of bleeding episodes. Not indicated for the treatment of VWD. It is available in four vial sizes: 250 IU, 500 IU, 1000 IU and 2000 IU. Store Adynovate in powder form at 2°to 8°C (36°to 46°F). Do not freeze.
• Corifact (CSL Behring)
CORIFACT is a factor XIII concentrate antihemophilic factor (Human). Indicated for adult and pediatric patients with congenital factor XIII deficiency for: 1) routine prophylactic treatment; and 2) perioperative management of surgical bleeding. It is available in 1000-1600 Units. Refrigerate Corifact at 2°to 8°C (36°to 46°F). Keep in original carton to protect from light. Do not freeze.
• Nuwiq (Octapharma)
NUWIQ is a recombinant antihemophilic coagulation Factor VIII indicated in adults and children with Hemophilia A for: 1) on-demand treatment and control of bleeding episodes; 2) perioperative management of bleeding; and 3) routine prophylaxis to reduce the frequency of bleeding episodes. Nuwiq is not indicated for the treatment of von Willebrand Disease. It is available in four vial sizes: 250 IU, 500 IU, 1000 IU and 2000 IU. Store at 2 – 8°C (35 – 46°F) for up to 24 months. Do not freeze.
• Miacalcin (Mylan Institutional)
MIACALCIN (calcitonin-salmon) synthetic injection is for subcutaneous or intramuscular use and is indicated for the following conditions: 1) hypercalcemia; 2) Paget’s disease of bone; and 3) postmenopausal osteoporosis. It is available as a sterile solution in individual 2 mL multi-dose vials containing 200 IU per mL, and should be refrigerated between 2 degrees to 8 degrees Centigrade.
• Zarxio (Sandoz Inc.)
ZARXIO (filgrastim-sndz) injection is for subcutaneous or intravenous use. It is a leukocyte growth factor indicated to: 1) patients with cancer receiving myelosuppressive chemotherapy; 2) patients with acute myeloid leukemia receiving induction or consolidation chemotherapy; 3) patients with cancer undergoing bone marrow transplantation; 4) patients undergoing autologous peripheral blood progenitor cell collection and therapy; and 5) patients with severe chronic neutropenia. This product must be stored in a refrigerator at 2 degrees to 8 degrees in the original pack to protect from light. Do not shake, do not freeze. Prior to injection, the product may be allowed to reach room temperature for a maximum of 24 hours.
• Imovax Rabies (Sanofi Pasteur)
IMOVAX Rabies is a vaccine indicated for pre-exposure and post-exposure prophylaxis against rabies and is approved for use in all age groups. The freeze-dried vaccine is stable if stored in the refrigerator between 2 degrees to 8 degrees Centigrade. Do not freeze. The product is a sterile, stable, freeze-dried suspension of rabies virus prepared from strain PM-1503-3M obtained from the Wistar Institute, Philadelphia, PA.
These products can be ordered from FFF Enterprise's BioSupply Online Ordering System or by calling Wow! Customer Care at (800) 843-7477.
|
